Democratized single-cell proteomics resolves cell state heterogeneity in skin tumors
Life Science Alliance · 2026
DOI: 10.26508/lsa.202603759 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2026. Verfasst von Joseph Inns und 4 weiteren Autor:innen. Beteiligte Einrichtung: Translational and Clinical Research Institute, Newcastle University; and NIHR Newcastle Biomedical Research Centre (BRC), Newcastle upon Tyne, UK joe…. Hauptthemen laut MEDLINE: Proteomics, Skin Neoplasms, Single-Cell Analysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR | NIHR Newcastle Biomedical Research Centre.
Abstract (Originalsprache)
Single-cell proteomics (SCP) reveals cellular heterogeneity and biological insights inaccessible to bulk analysis. Existing limitations are cost, sample loss during processing, and accessibility to state-of-the-art instrumentation. We describe a label-free SCP methodology in human tissue, combining FACS, oil-immersion cell handling, mass spectrometry, and neural-network–derived spectral libraries, which address these issues. We tested this methodology in a skin tumor syndrome, CYLD cutaneous syndrome (CCS), assessing tumor heterogeneity. Using a Bruker timsTOF HT platform, we quantified >4,000 proteins, averaging ∼700 per cell, through a cost-effective pipeline without specialised liquid handling infrastructure. By using preexisting bioinformatic tools from the scRNA-seq field, we implemented a robust analysis methodology, discriminating between macrophages, dendritic cells, and tumor keratinocytes, in an unbiased analysis of 419 CCS tumor cells. We validated the biological accuracy of cell annotations by cross referencing with each cell’s FACS markers. Furthermore, we identified a novel CCS tumor-associated macrophage population, which carried a tumor microenvironment remodelling signature. Our findings demonstrate an accessible SCP technology capable of yielding novel biological discoveries in clinical tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Translational and Clinical Research Institute, Newcastle University; and NIHR Newcastle Biomedical Research Centre (BRC), Newcastle upon Tyne, UK joe.inns@newcastle.ac.uk.
- Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
- Translational and Clinical Research Institute, Newcastle University; and NIHR Newcastle Biomedical Research Centre (BRC), Newcastle upon Tyne, UK.
- Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
- Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
ORCID-Profile: Joseph Inns, Weng Wi Ng, Matthias Trost, Neil Rajan
Förderung
- NIHR | NIHR Newcastle Biomedical Research Centre
Zitieren
APA
Inns, J., Frey, A. M., Ng, W. W., Trost, M., & Rajan, N. (2026). Democratized single-cell proteomics resolves cell state heterogeneity in skin tumors. Life Science Alliance. https://doi.org/10.26508/lsa.202603759
Vancouver
Inns J, Frey AM, Ng WW, Trost M, Rajan N. Democratized single-cell proteomics resolves cell state heterogeneity in skin tumors. Life Science Alliance. 2026. doi:10.26508/lsa.202603759
BibTeX
@article{Inns2026,
author = {Inns, Joseph and Frey, Andrew Michael and Ng, Weng Wi and Trost, Matthias and Rajan, Neil},
title = {Democratized single-cell proteomics resolves cell state heterogeneity in skin tumors},
journal = {Life Science Alliance},
year = {2026},
doi = {10.26508/lsa.202603759}
}
EUVIMED